- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04257279
Prospective Robotic Global Research Study (PROGRESS) (PROGRESS)
October 15, 2021 updated by: Globus Medical Inc
The purpose of this study is to prospectively review outcomes of patients who have surgery with the ExcelsiusGPS™ robotics system in order to analyze screw placement accuracy.
Patient demographics, intraoperative data and radiographic imaging to determine screw placement accuracy will be collected and reviewed.
This information will be compared in a separate study to retrospectively collected data from sites who have done a similar number of cases without the robot.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Samantha Greeley, BS
- Phone Number: 2509 6109301800
- Email: sgreeley@globusmedical.com
Study Contact Backup
- Name: Brandon Bucklen, PhD
- Phone Number: 2517 6109301800
- Email: bbucklen@globusmedical.com
Study Locations
-
-
South Carolina
-
Mount Pleasant, South Carolina, United States, 29464
- Recruiting
- Southeastern Spine Institute
-
Contact:
- Karen Blakely, RN
- Phone Number: 843-284-4738
- Email: karen.blakely@southeasternspine.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least 18 years of age and a maximum age of 85 years
- Require surgery that includes posterior stabilization with screws to be inserted in cervical, thoracic, lumbar spine or sacrum
- Able to sign Informed Consent
Exclusion Criteria:
- Previous fusion or fusion attempt at index level(s)
- DEXA score of -2.5 or below (only if clinically indicated - optional)
- Presence of a disease entity or condition which totally precludes possibility of bony fusion (e.g. metastatic cancer, HIV, long term use of steroids, etc.)
- History of substance abuse (drugs or alcohol)
- Mentally incompetent or prisoner
- Worker's compensation
- Pregnant or intention to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Robotic
Patients receiving spine surgery with posterior stabilization placed by ExcelsiusGPS
|
The ExcelsiusGPS™ is a Robotic Positioning System that includes a computer controlled robotic arm, hardware, and software that enables real time surgical navigation and robotic guidance using radiological patient images (pre-operative CT, intra-operative CT and fluoroscopy), using a dynamic reference base and positioning camera.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Rating Scale
Time Frame: Baseline
|
Pain rating scale
|
Baseline
|
|
Numeric Rating Scale
Time Frame: 2 weeks
|
Pain rating scale
|
2 weeks
|
|
Numeric Rating Scale
Time Frame: 3 months
|
Pain rating scale
|
3 months
|
|
Numeric Rating Scale
Time Frame: 6 months
|
Pain rating scale
|
6 months
|
|
Numeric Rating Scale
Time Frame: 12 months
|
Pain rating scale
|
12 months
|
|
Numeric Rating Scale
Time Frame: 24 months
|
Pain rating scale
|
24 months
|
|
Oswestry Disability Index
Time Frame: Baseline
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
Baseline
|
|
Oswestry Disability Index
Time Frame: 2 weeks
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
2 weeks
|
|
Oswestry Disability Index
Time Frame: 3 months
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
3 months
|
|
Oswestry Disability Index
Time Frame: 6 months
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
6 months
|
|
Oswestry Disability Index
Time Frame: 12 months
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
12 months
|
|
Oswestry Disability Index
Time Frame: 24 months
|
Index derived from the Oswestry Low Back Pain Questionnaire
|
24 months
|
|
SF-12
Time Frame: Baseline
|
12-Item short form health survey
|
Baseline
|
|
SF-12
Time Frame: 2 weeks
|
12-Item short form health survey
|
2 weeks
|
|
SF-12
Time Frame: 3 months
|
12-Item short form health survey
|
3 months
|
|
SF-12
Time Frame: 6 months
|
12-Item short form health survey
|
6 months
|
|
SF-12
Time Frame: 12 months
|
12-Item short form health survey
|
12 months
|
|
SF-12
Time Frame: 24 months
|
12-Item short form health survey
|
24 months
|
|
Screw Placement Accuracy
Time Frame: 2 weeks
|
Gertzbein Robbins Scale for screw accuracy
|
2 weeks
|
|
Complications
Time Frame: through study completion, 2 years
|
Adverse Event
|
through study completion, 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 18, 2019
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
April 29, 2019
First Submitted That Met QC Criteria
February 4, 2020
First Posted (Actual)
February 6, 2020
Study Record Updates
Last Update Posted (Actual)
October 19, 2021
Last Update Submitted That Met QC Criteria
October 15, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RGC18-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Disc Disease
-
Locate Bio Pty LtdRecruitingDegenerative Disc Disease | Lumbar Disc Disease | Spine Disease | Lumbar Spine DegenerationAustralia, United States
-
Providence Medical Technology, Inc.RecruitingRadiculopathy Lumbar | Degenerative Lumbar Disc DiseaseUnited States
-
Cantonal Hospital of St. GallenProf. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St.... and other collaboratorsCompletedLumbar Spinal Stenosis | Lumbar Disc Disease | Lumbar Spine DegenerationSwitzerland
-
[Redacted]WithheldLumbar Disc Herniation | Degenerative Disc Disease | Lumbar Spinal Stenosis | Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Radiculopathy | Lumbar Disc Disease | Spine Disease | Lumbar Spine Degeneration | Degenerative SpondylolisthesisAustralia
-
Spinal ElementsCompletedLumbar Disc DiseaseUnited States
-
Ramsay Générale de SantéCompletedSurgical Procedure, Unspecified | Lumbar Disc DiseaseFrance
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Rush University Medical CenterCompletedLumbar Degenerative Disc Disease | Lumbar Degenerative Disease | Degenerative SpineUnited States
-
Medipol UniversityCompletedLumbar Disc Herniation | Lumbar Disc DiseaseTurkey (Türkiye)
Clinical Trials on ExcelsiusGPS™
-
BaroNova, Inc.Completed
-
London Health Sciences CentreUniversity of Western Ontario, Canada; Synaptive MedicalUnknownBrain Damage, Chronic | Cerebellar Cognitive Affective Syndrome | Cerebellar Mutism
-
Asklepios Kliniken Hamburg GmbHUniversity of KielCompletedAirway Management | Laryngeal Mask Airway | Fibreoptic Intubation
-
CereVasc IncAlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...Active, not recruitingHydrocephalus | Hydrocephalus, CommunicatingArgentina
-
Andrew ParrentUniversity of Western Ontario, Canada; Synaptive MedicalUnknownTemporal Lobe Epilepsy
-
Medtronic CardiovascularCompletedAortic AneurysmGermany, United States, Netherlands, Switzerland, United Kingdom, New Zealand, Spain, Australia, Italy, Sweden, France, Austria, Slovakia
-
Gülçin Özalp GerçekerCompletedCatheter Complications | Catheter LeakageTurkey
-
GlaxoSmithKlineCompletedTetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type bKorea, Republic of
-
GlaxoSmithKlineCompletedHepatitis B | Hepatitis AGermany, Belgium, Czechia
-
Evasc Medical Systems Corp.Withdrawn